BioSphere Medical, Inc. and DuPont Applied Biosciences Sign Strategic Collaboration Agreement

BioSphere Medical, Inc. (NASDAQ: BSMD) (“BioSphere”), a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors, and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy, today announced that it has signed a strategic collaboration agreement with DuPont Applied BioSciences (DuPont) under which the companies intend to evaluate potential peripheral vascular and embolotherapy research, development, and manufacturing engineering projects